No Data
No Data
Mind Medicine Price Target Announced at $20.00/Share by Chardan Capital
Mind Medicine Initiated at Buy by Chardan Capital
Mind Medicine to Join Nasdaq Biotechnology Index
Express News | MindMed To Be Added To The Nasdaq Biotechnology Index, Effective At Market Open On December 23, 2024
Mind Medicine Analyst Ratings
Oppenheimer Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $20
No Data